Rhythm Pharmaceuticals, Inc. - Common Stock (NQ:RYTM)
Price and Volume
Detailed Quote| Volume | 80,545 |
| Open | 88.79 |
| Bid (Size) | 89.35 (100) |
| Ask (Size) | 89.63 (100) |
| Prev. Close | 87.84 |
| Today's Range | 87.84 - 90.78 |
| 52wk Range | 58.71 - 122.20 |
| Shares Outstanding | 66,684,077 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
My Top 3 Stocks to Buy in May ↗
May 07, 2026
Rhythm (RYTM) Q1 2026 Earnings Call Transcript ↗
May 06, 2026
Is This Weight Loss Drug Stock a Buy After a New Approval? ↗
March 31, 2026
Rhythm Pharma (RYTM) Earnings Call Transcript ↗
February 26, 2026
Frequently Asked Questions
Is Rhythm Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Rhythm Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Rhythm Pharmaceuticals, Inc. - Common Stock trade on?
Rhythm Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rhythm Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Rhythm Pharmaceuticals, Inc. - Common Stock is RYTM on the Nasdaq Stock Market
What is the current price of Rhythm Pharmaceuticals, Inc. - Common Stock?
The current price of Rhythm Pharmaceuticals, Inc. - Common Stock is 89.53
When was Rhythm Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Rhythm Pharmaceuticals, Inc. - Common Stock was at 05/26/26 01:28 PM ET
What is the market capitalization of Rhythm Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Rhythm Pharmaceuticals, Inc. - Common Stock is 5.97B
How many shares of Rhythm Pharmaceuticals, Inc. - Common Stock are outstanding?
Rhythm Pharmaceuticals, Inc. - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube